Patent · US Active

Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

US9102632B2 · kind B2 · utility

0Cited by
2References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2013
Grant dateAug 11, 2015
Priority date—
Expiry dateDec 17, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D241/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The treatment of diabetes and associated pathologies is achieved by administering the pyrazinone compounds of formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.